References
- Hahn GM Hyperthermia and Cancer, 1st edn. New York: Plenum Press, 1982.
- Oleson JR, Calderwood SK, Coughlin CT, Dewhirst MW, Gerweck LE, Gibbs FA Jr, Kapp DS. Biological and clinical aspects of hyperthermia in cancer therapy. Am J Clin Oncol 1988; 11: 368–80.
- Lee KY, Lee YL, Kim CD, Chang TM, Chey WY. Mechanism of action of insulin on pancreatic exocrine secretion in perfused rat pancreas. Am J Physiol 1994; 267: G207–12.
- Sliutz G, Karlseder J, Tempfer C, Orel L, Holzer G, Simon MM. Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: impli-cation of quercetin as sensitiser in chemotherapy. Br J Cancer 1996; 74: 172–7.
- Elia G, Amici C, Rossi A, Santoro MG. Modulation of prostaglandin Al-induced ther-motolerance by quercetin in human leukemic cells: role of heat shock protein 70. Cancer Res 1996; 56: 210–7.
- Georgopoulos C, Welch WJ. Role of the major heat shock proteins as molecular chaper-ones. Annu Rev Cell Biol 1993; 9: 601–34.
- Schlesinger MJ. How the cell copes with stress and the function of heat shock proteins. Pediatr Res 1994; 36: 1–6.
- Lindquist S, Craig EA. The heat-shock proteins. Annu Rev Genet 1988; 22: 631–77.
- Calderwood SK. Molecular strategies for sensing and responding to stress. In: Proceedings of the 86th Annual Meeting of the American Association for Cancer Research, 1995, 682, Cadmir: Phil.
- Wu C. Heat shock transcription factors: structure and regulation. Annu Rev Cell Dev Biol 1995; 11: 441–69.
- Hosokawa N, Hirayoshi K, Kudo H, Takechi H, Aoike A, Kawai K, et al. Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids. Mol Cell Biol 1992; 12: 3490–8.
- Price BD, Calderwood SK. Ca2+ is essential for multistep activation of the heat shock factor in permeabilized cells. Mol Cell Biol 1991; 11: 3365–8.
- Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ, McGuire WL. Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst 1993; 85: 570–4.
- Asea A, Jones E, Zhao M-J, Kabingu E, Mallick R, Stevenson MA, Calderwood S K. HSP70 inhibits apoptosis in prostate cancer cells in vitro and in cell-free extracts. 2001, submitted for publication.
- Li X, Brown SL, Hill RP. Factors influencing the thermosensitivity of two rodent tumors. Radiat Res 1992; 130: 211–9.
- Brown SL, Li XL, Pai HH, Worthington AE, Hill RP, Hunt JW. Observations of thermal gradients in perfused tissues during water bath heating. Int J Hyperthermia 1992; 8: 275–87.
- Brown SL, Hunt JW, Hill RP. Differential thermal sensitivity of tumour and normal tissue microvascular response during hyperthermia. Int J Hyperthermia 1992; 8: 501–14.
- Herman TS, Teicher BA, Coleman CN. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo. Cancer Res 1990; 50: 5055–9.
- Agullo G, Gamet L, Besson C, Demigne C, Remesy C. Quercetin exerts a preferential cytotoxic effect on active dividing colon carcinoma HT29 and Caco-2 cells. Cancer Lett 1994; 87: 55–63.
- van Rijn J, van den Berg J. Flavonoids as enhancers of x-ray-induced cell damage in hepatoma cells. Clin Cancer Res 1997; 3: 1775–9.
- Ferry DR, Smith A, Malkhandi J, Fyfe DW, deTakats PG, Anderson D, Baker J, Kerr DJ. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res 1996; 2: 659–68.
- Kyriakidis SM, Sotiroudis TG, Evangelopoulos AE. Interaction of flavonoids with rabbit muscle phosphorylase kinase. Biochim Biophys Acta 1986; 871: 121–9.
- Kim JH, Kim SH, Alfieri AA, Young CW. Quercetin, an inhibitor of lactate transport and a hyperthermic sensitizer of HeLa cells. Cancer Res 1984; 44: 102–6.
- Wei YQ, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A. Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res 1994; 54: 4952–7.